Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epistasis regulates genetic control of cardiac hypertrophy.

Nature cardiovascular research·2025
Same author

Epistasis regulates genetic control of cardiac hypertrophy.

Research square·2023
Same author

Deciphering epistatic genetic regulation of cardiac hypertrophy.

medRxiv : the preprint server for health sciences·2023
Same author

Constructing a polygenic risk score for childhood obesity using functional data analysis.

Econometrics and statistics·2023
Same author

Fibroblast Growth Factor Receptor 1 Drives the Metastatic Progression of Prostate Cancer.

European urology oncology·2021
Same author

Association of MyProstateScore (MPS) with prostate cancer grade in the radical prostatectomy specimen.

Urologic oncology·2021

Related Experiment Video

Updated: May 21, 2025

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

114

A simplified MyProstateScore2.0 for high-grade prostate cancer.

Tiffany M Tang1, Yuping Zhang2,3, Ana M Kenney4

  • 1Department of Statistics, University of Michigan, Ann Arbor, MI, USA.

Cancer Biomarkers : Section a of Disease Markers
|March 20, 2025
PubMed
Summary

A new 7-gene prostate cancer (PCa) urine test, simplified MyProstateScore2.0 (sMPS2), offers accurate, non-invasive screening. This accessible test aims for widespread clinical adoption in diagnosing high-grade PCa.

Keywords:
PCS for veridical data sciencemachine learningprostate cancertrustworthy AIurine biomarker

More Related Videos

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

596
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

16.5K

Related Experiment Videos

Last Updated: May 21, 2025

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

114
Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

596
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

16.5K

Area of Science:

  • Urology
  • Biomarker Discovery
  • Genomics

Background:

  • Prostate-specific antigen (PSA) screening for prostate cancer (PCa) has limited diagnostic accuracy.
  • Innovative solutions like the 18-gene MyProstateScore2.0 (MPS2) urine test improve PCa detection.
  • There is a need for more accessible, non-invasive PCa diagnostic tools.

Purpose of the Study:

  • To develop a simplified 7-gene urine test (sMPS2) for high-grade PCa.
  • To achieve diagnostic accuracy comparable to the 18-gene MPS2 test.
  • To enhance accessibility for routine clinical care through a reduced gene set.

Main Methods:

  • Utilized the Predictability, Computability, and Stability (PCS) framework for data science.
  • Employed a stability-driven PCS ranking procedure for gene selection.
  • Validated the sMPS2 model on a blinded external cohort.

Main Results:

  • The 7-gene sMPS2 achieved an AUROC of 0.784 for predicting high-grade PCa.
  • Performance was only 2.3% lower than the 18-gene MPS2.
  • The gene selection process ensured robustness and predictive power.

Conclusions:

  • The 7-gene sMPS2 demonstrates high accuracy for non-invasive PCa screening.
  • This simplified test offers a viable alternative for broader clinical application.
  • sMPS2 has the potential to significantly expand the reach of PCa screening.